Cerevance Showcases Positive Phase 2 Results Demonstrating Significant Reduction in OFF Time with Solengepras as an Adjunctive Treatment in Parkinsons Disease
December 05, 2025 21:00 ET | Source: Cerevance, Inc. Phase 2 results…
Press Release: Sanofi and Regenerons Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria
Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the…
Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial
Company Announces Approximately $30 Million in Cash and Short-Term Investments Following Its…
Foundation for Advancement of Micro Enterprises (FAME) Transforms Dairy Farming for Over 2 Lakh Rural Farmers Across Five States
MUMBAI, India, Nov. 24, 2025 /PRNewswire/ -- The Foundation for Advancement of Micro…
Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference
November 21, 2025 16:30 ET | Source: Olema Oncology SAN FRANCISCO, Nov.…
Internet Watch Foundation and Public Interest Registry Extend Online Safety Initiative to Disrupt Criminal ‘brands’ Selling Child Sexual Abuse
A new sponsorship programme aims to help domain registrars 'disrupt' criminal businesses…
Apollomics, Inc. Company Operational Continuity Update
October 13, 2025 21:22 ET | Source: Apollomics Inc. FOSTER CITY, Calif.,…
Pictor Secures Funding to Accelerate U.S. Expansion through Partner-Informed Proteomics Solutions
CARLSBAD, Calif., Sept. 23, 2025 /PRNewswire/ -- Pictor Holdings Inc., a global leader…
Cullinan Therapeutics to Participate in Fireside Chat at the Stifel 2025 Virtual Immunology and Inflammation Forum
September 12, 2025 07:00 ET | Source: Cullinan Therapeutics, Inc. CAMBRIDGE, Mass.,…
Apexon Unveils AgentRise, a Next-Gen Agentic AI Platform for Intelligent Enterprises
AgentRise accelerates enterprise adoption at scale with nine targeted capabilities that turn…